SPHERA FUNDS MANAGEMENT LTD. - EVOKE PHARMA INC ownership

EVOKE PHARMA INC's ticker is EVOK and the CUSIP is 30049G104. A total of 23 filers reported holding EVOKE PHARMA INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
SPHERA FUNDS MANAGEMENT LTD. ownership history of EVOKE PHARMA INC
ValueSharesWeighting
Q4 2018$3,499,000
-16.8%
1,410,9460.0%0.39%
-18.4%
Q3 2018$4,205,000
+19.2%
1,410,9460.0%0.48%
-0.6%
Q2 2018$3,527,000
+330.6%
1,410,946
+258.2%
0.49%
+291.9%
Q1 2018$819,000
-52.9%
393,852
-48.8%
0.12%
-39.2%
Q4 2017$1,738,000
-8.9%
769,149
+34.7%
0.20%
-25.0%
Q3 2017$1,907,000
+49.0%
571,022
+14.2%
0.27%
+25.3%
Q2 2017$1,280,000
-17.4%
500,0000.0%0.22%
-28.4%
Q1 2017$1,550,000500,0000.30%
Other shareholders
EVOKE PHARMA INC shareholders Q1 2017
NameSharesValueWeighting ↓
Wambolt & Associates, LLC 33,165$29,0000.02%
STATE OF MICHIGAN RETIREMENT SYSTEM 400,000$344,0000.00%
A.R.T. Advisors, LLC 36,954$32,0000.00%
NORTHERN TRUST CORP 33,997$29,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 199,678$171,0000.00%
CITIGROUP INC 500$00.00%
MORGAN STANLEY 1,450$1,0000.00%
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 36,700$32,0000.00%
BlackRock Inc. 54,940$47,0000.00%
View complete list of EVOKE PHARMA INC shareholders